The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Diabetes and Stroke: Epidemiology, Pathophysiology, Pharmaceuticals and Outcomes
Open accessAbstract
There has been a significant increase in obesity rates worldwide with the corresponding surge in diabetes. Diabetes causes various microvascular and macrovascular changes often culminating in major clinical complications, 1 of which, is stroke. Although gains have been made over the last 2 decades in reducing the burden of stroke, the recent rise in rates of diabetes threatens to reverse these advances. Of the several mechanistic stroke subtypes, individuals with diabetes are especially susceptible to the consequences of cerebral small vessel diseases. Hyperglycemia confers greater risk of stroke occurrence. This increased risk is often seen in individuals with diabetes and is associated with poorer clinical outcomes (including higher mortality), especially following ischemic stroke. Improving stroke outcomes in individuals with diabetes requires prompt and persistent implementation of evidence‐based medical therapies as well as adoption of beneficial lifestyle practices.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chobanian, A. V. (2003) · JAMA · doi:10.1001/jama.289.19.2560 · Cited by 25,386
Zhang, Q., Wang, C., Zheng, M., Li, Y., Li, J., Zhang, L., Shang, X., & Yan, C. (2015) · Cerebrovascular Diseases · doi:10.1159/000369778 · Cited by 11,533
James, P. A., Oparil, S., Carter, B. L., Cushman, W. C., Dennison-Himmelfarb, C., Handler, J., Lackland, D. T., LeFevre, M. L., MacKenzie, T. D., Ogedegbe, O., et al. (2014) · JAMA · doi:10.1001/jama.2013.284427 · Cited by 7,950
Jauch, E. C., Saver, J. L., Adams, H. P., Bruno, A., Connors, J. J. (., Demaerschalk, B. M., Khatri, P., McMullan, P. W., Qureshi, A. I., Rosenfield, K., et al. (2013) · Stroke · doi:10.1161/str.0b013e318284056a · Cited by 7,634
(1996) · The Lancet · doi:10.1016/s0140-6736(96)09457-3 · Cited by 6,503
Stearne, M. R., Palmer, S. L., Hammersley, M. S., Franklin, S. L., Spivey, R. S., Lévy, J., Tidy, C. R., Bell, N. J., Steemson, J., Barrow, B. A., et al. (1998) · UCL Discovery (University College London) · Cited by 6,094
Kernan, W. N., Ovbiagele, B., Black, H. R., Bravata, D. M., Chimowitz, M. I., Ezekowitz, M. D., Fang, M. C., Fisher, M., Furie, K. L., Heck, D. V., et al. (2014) · Stroke · doi:10.1161/str.0000000000000024 · Cited by 5,170
Self-citationIntensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
(2005) · New England Journal of Medicine · doi:10.1056/nejmoa052187 · Cited by 5,138
The Emerging Risk Factors Collaboration (2010) · The Lancet · doi:10.1016/s0140-6736(10)60484-9 · Cited by 5,125
Dormandy, J. A., Charbonnel, B., Eckland, D. J., Erdmann, E., Massi-Benedetti, M., Moules, I. K., Skene, A. M., Tan, M. H., Lefèbvre, P. J., Murray, G. D., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67528-9 · Cited by 4,129
Hemphill, J. C., Greenberg, S. M., Anderson, C. S., Becker, K., Bendok, B. R., Cushman, M., Fung, G. L., Goldstein, J. N., Macdonald, R. L., Mitchell, P. H., et al. (2015) · Stroke · doi:10.1161/str.0000000000000069 · Cited by 3,994
Effects of intensive blood-pressure control in type 2 diabetes mellitus
(2010) · New England Journal of Medicine · doi:10.1056/nejmoa1001286 · Cited by 3,598
Effect of a multifactorial intervention on mortality in type 2 diabetes
Gæde, P., Lund-Andersen, H., Parving, H.-H., & Pedersen, O. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706245 · Cited by 3,465 · cited 1×
“3 years of follow-up, 6 individuals (6 strokes) in the INT group and 18 individuals (30 strokes) in the conventional group suffered strokes.(31) Frequently, individuals with diabetes have coexistent hypertension that is another modifiable risk factor for stroke.”
BackgroundO'Donnell, M. J., Xavier, D., Liu, L., Zhang, H., Chin, S. L., Rao-Melacini, P., Rangarajan, S., Islam, S., Pais, P., McQueen, M. J., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60834-3 · Cited by 3,448
Heidenreich, P. A., Trogdon, J. G., Khavjou, O. A., Butler, J., Dracup, K., Ezekowitz, M. D., Finkelstein, E. A., Hong, Y., Johnston, S. C., Khera, A., et al. (2011) · Circulation · doi:10.1161/cir.0b013e31820a55f5 · Cited by 3,208
Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes
The Look AHEAD Research Group (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1212914 · Cited by 2,908
(2004) · PsycEXTRA Dataset · doi:10.1037/e442802008-001 · Cited by 2,875
Dennis, M. S. (1996) · The Lancet · Cited by 2,728
Probability of stroke: a risk profile from the Framingham Study.
Wolf, P. A., D'Agostino, R. B., Belanger, A. J., & Kannel, W. B. (1991) · Stroke · doi:10.1161/01.str.22.3.312 · Cited by 1,782
The J-Curve Phenomenon in Hypertension
Kang, Y.-Y., & Wang, J.-G. (2016) · Pulse · doi:10.1159/000446922 · Cited by 1,530
Kinaan, M., Ding, H., & Triggle, C. R. (2015) · Medical Principles and Practice · doi:10.1159/000381643 · Cited by 1,515
Pioglitazone after Ischemic Stroke or Transient Ischemic Attack
Kernan, W. N., Viscoli, C. M., Furie, K. L., Young, L. H., Inzucchi, S. E., Gorman, M., Guarino, P. D., Lovejoy, A. M., Peduzzi, P. N., Conwit, R., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1506930 · Cited by 1,124
European Stroke Initiative Recommendations for Stroke Management – Update 2003
(2003) · Cerebrovascular Diseases · doi:10.1159/000072554 · Cited by 635
Weir, C. J., Murray, G. D., Dyker, A. G., & Lees, K. R. (1997) · BMJ · doi:10.1136/bmj.314.7090.1303 · Cited by 522
Admission glucose level and clinical outcomes in the NINDS rt-PA Stroke Trial
Bruno, A., Levine, S. R., Frankel, M. R., Brott, T. G., Lin, Y., Tilley, B. C., Lyden, P. D., Broderick, J. P., Kwiatkowski, T. G., Fineberg, S. E., et al. (2002) · Neurology · doi:10.1212/wnl.59.5.669 · Cited by 516
Short-term Predictors of Incident Stroke in Older Adults: The Cardiovascular Health Study
Manolio, T. A., Kronmal, R. A., Burke, G. L., O'Leary, D. H., & Price, T. R. (1996) · Stroke · doi:10.1161/01.str.27.9.1479 · Cited by 299
Treatment of Hyperglycemia In Ischemic Stroke (THIS): A Randomized Pilot Trial
Bruno, A., Kent, T. A., Coull, B. M., Shankar, R. R., Saha, C., Becker, K. J., Kissela, B. M., & Williams, L. S. (2008) · Stroke · doi:10.1161/strokeaha.107.493544 · Cited by 265
Hyperglycemia Exacerbates Brain Edema and Perihematomal Cell Death After Intracerebral Hemorrhage
Song, E.-C., Chu, K., Jeong, S.-W., Jung, K.-H., Kim, S.-H., Kim, M., & Yoon, B.-W. (2003) · Stroke · doi:10.1161/01.str.0000088060.83709.2c · Cited by 263
Stroke patterns, etiology, and prognosis in patients with diabetes mellitus
Karapanayiotides, T., Piechowski-Jozwiak, B., van Melle, G., Bogousslavsky, J., & Devuyst, G. (2004) · Neurology · doi:10.1212/01.wnl.0000123252.55688.05 · Cited by 257
Effect of pre-diabetes on future risk of stroke: meta-analysis
Lee, M., Saver, J. L., Hong, K.-S., Song, S., Chang, K.-H., & Ovbiagele, B. (2012) · BMJ · doi:10.1136/bmj.e3564 · Cited by 216
Self-citationProspective Study of Type 1 and Type 2 Diabetes and Risk of Stroke Subtypes
Janghorbani, M., Hu, F. B., Willett, W. C., Li, T. Y., Manson, J. E., Logroscino, G., & Rexrode, K. M. (2007) · Diabetes Care · doi:10.2337/dc06-2363 · Cited by 212
Lachin, J. M., Orchard, T. J., Nathan, D. M., & for the DCCT/EDIC Research Group (2014) · Diabetes Care · doi:10.2337/dc13-2116 · Cited by 206 · cited 1×
“018).(28) The INT (with the aim of achieving near-normal blood glucose and glycosylated hemoglobin concentrations) group in DCCT consisted of 3 or more daily injections of insulin or treatment with an external insulin pump, with dose adjustments based on at least 4 self-monitored glucose measurements per day.”
MethodInsulin for glycaemic control in acute ischaemic stroke
Bellolio, M. F., Gilmore, R. M., & Ganti, L. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005346.pub4 · Cited by 183
Diabetes Mellitus: A Risk Factor for Ischemic Stroke in a Large Biracial Population
Khoury, J. C., Kleindorfer, D., Alwell, K., Moomaw, C. J., Woo, D., Adeoye, O., Flaherty, M. L., Khatri, P., Ferioli, S., Broderick, J. P., et al. (2013) · Stroke · doi:10.1161/strokeaha.113.001318 · Cited by 167
Glucose Regulation in Acute Stroke Patients (GRASP) Trial: A Randomized Pilot Trial
Johnston, K. C., Hall, C. E., Kissela, B. M., Bleck, T. P., & Conaway, M. R. (2009) · Stroke · doi:10.1161/strokeaha.109.561498 · Cited by 164
Pandolfi, A., Giaccari, A., Cilli, C., Alberta, M. M., Morviducci, L., De Filippis, E. A., Buongiorno, A., Pellegrini, G., Capani, G., & Consoli, A. (2001) · Acta Diabetologica · doi:10.1007/s005920170016 · Cited by 144
Quast, M. J., Wei, J., Huang, N., Brunder, D. G., Sell, S. L., Gonzalez, J. M., Hillman, G. R., & Kent, T. A. (1997) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199705000-00009 · Cited by 126
Tuttolomondo, A., Pinto, A. V., Salemi, G., Raimondo, D. D., Sciacca, R. D., Fernández, P., Ragonese, P., Savettieri, G., & Licata, G. (2007) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2007.02.003 · Cited by 121
Diabetes mellitus and ischemic stroke in the young: Clinical features and long-term prognosis
Putaala, J., Liebkind, R., Gordin, D., Thorn, L. M., Haapaniemi, E., Forsblom, C. M., Groop, P., Kaste, M., & Tatlisumak, T. (2011) · Neurology · doi:10.1212/wnl.0b013e31821cccc2 · Cited by 112
Hemorrhagic transformation of ischemic stroke in diabetics on sulfonylureas
Kunte, H., Busch, M. A., Trostdorf, K., Vollnberg, B., Harms, L., Mehta, R. I., Castellani, R. J., Mandava, P., Kent, T. A., & Simard, J. M. (2012) · Annals of Neurology · doi:10.1002/ana.23680 · Cited by 104
Bruno, A., Durkalski, V., Hall, C. E., Juneja, R., Barsan, W. G., Janis, S., Meurer, W. J., Fansler, A. C., & Johnston, K. C. (2013) · International Journal of Stroke · doi:10.1111/ijs.12045 · Cited by 98
Type 2 diabetes and risk of non-embolic ischaemic stroke in Japanese men and women
Iso, H., Imano, H., Kitamura, A., Sato, S., Naito, Y., Tanigawa, T., Ohira, T., Yamagishi, K., Iida, M., & Shimamoto, T. (2004) · Diabetologia · doi:10.1007/s00125-004-1587-0 · Cited by 97
Cui, R., Iso, H., Yamagishi, K., Saito, I., Kokubo, Y., Inoue, M., & Tsugane, S. (2011) · Stroke · doi:10.1161/strokeaha.111.614313 · Cited by 87
Pioglitazone after Ischemic Stroke or Transient Ischemic Attack
Viscoli, C. M., Kernan, W. N., & Young, L. H. (2016) · New England Journal of Medicine · doi:10.1056/nejmc1605904 · Cited by 50
Long Term Postischemic Stroke Mortality in Diabetes
Kamalesh, M., Shen, J., & Eckert, G. J. (2008) · Stroke · doi:10.1161/strokeaha.108.517441 · Cited by 49
Cited by
Macrovascular Complications of Type 2 Diabetes Mellitus
Viigimaa, M., Sachinidis, A., Toumpourleka, M., Koutsampasopoulos, K., Alliksoo, S., & Titma, T. (2020) · Current Vascular Pharmacology · doi:10.2174/1570161117666190405165151 · Cited by 387
Benefits and harms of intensive glycemic control in patients with type 2 diabetes
Rodriguez-Gutierrez, R., Gonzalez-Gonzalez, J. G., Zuñiga-Hernandez, J. A., & McCoy, R. G. (2019) · BMJ · doi:10.1136/bmj.l5887 · Cited by 152
Ren, Z., & Fu, X. (2021) · International Journal of General Medicine · doi:10.2147/ijgm.s327075 · Cited by 15
Evans, M., Husain, M., Srivastava, A., Mangla, K. K., Kuhlman, A. B., & Lingvay, I. (2024) · Advances in Therapy · doi:10.1007/s12325-023-02750-4 · Cited by 13
Metadata
- Authors
- Chen, R., Ovbiagele, B., & Feng, W.
- Venue
- The American Journal of the Medical Sciences
- Publisher
- Elsevier BV
- Published
- 2016-04
- Volume
- 351
- Issue
- 4
- Pages
- 380-386
- ISSN
- 0002-9629 (ISSN-L)
- OpenAlex
- W2337004113
- Cited by
- 642
- References
- 46
- FWCI
- 26.17
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.